Immunome, Inc.IMNMNASDAQ

Revenue (LTM)

$7M

-23.2% YoY

Net Income (LTM)

$-212M

+27.5% YoY

Free Cash Flow

$-201M

Revenue CAGR (5Y)

—

Marginsdeclining

FCF($0.2B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	0	0	14	9↓35.5%	7↓23.2%
Gross Profit	0	0	14	9↓35.5%	4↓55.9%
Operating Income	-25	-37↓46.4%	-110↓196.8%	-306↓179.2%	-214↑30.0%
Net Income	-25	-37↓49.3%	-107↓189.5%	-293↓174.3%	-212↑27.5%
EBITDA	-24	-36↓48.3%	-28↑22.8%	-151↓440.6%	-211↓39.5%
EPS Diluted	-2.14	-3.09↓44.4%	-5.38↓74.1%	-5.00↑7.1%	-2.43↑51.4%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	49	20↓58.7%	99↑385.6%	143↑45.3%	653↑355.9%
Total Current Assets	57	23↓60.0%	145↑538.9%	221↑53.0%	661↑198.5%
Total Assets	58	24↓58.5%	149↑517.7%	240↑61.7%	683↑184.4%
Total Current Liabilities	10	7↓24.6%	22↑197.8%	54↑148.8%	45↓17.2%
Total Liabilities	10	7↓24.1%	29↑287.6%	59↑106.1%	49↓17.3%
Total Equity	48	17↓65.4%	120↑619.9%	181↑51.1%	634↑250.1%
Total Debt	0	0↓8.2%	2↑467.0%	5↑192.8%	4↓20.2%
Net Debt	-49	-20↑59.0%	-97↓384.4%	-139↓42.8%	-650↓369.0%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-18	-29↓57.4%	-8↑73.6%	-111↓1364.0%	-191↓72.3%
Capital Expenditure	-0	-0↓213.9%	-1↓235.1%	-54↓6339.0%	-10↑81.9%
Free Cash Flow	-18	-29↓58.1%	-8↑71.0%	-164↓1856.2%	-201↓22.1%
Stock-Based Comp	3	5↑54.6%	6↑16.7%	16↑153.1%	26↑63.1%
Net Change in Cash	9	-29↓405.5%	78↑371.1%	45↓43.0%	510↑1042.2%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance